
The 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.

The 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.

Health care providers participating in the 340B program are prohibited from contributing to duplicate discounts, or the scenario that exists when a manufacturer provides a discounted 340B price and a rebate to Medicaid for the same drug.

Published: July 15th 2018 | Updated:

Published: December 2nd 2018 | Updated: